Molecular interaction studies of trimethoxy flavone with human serum albumin

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Gokara, Mahesh ^a   Sudhamalla, Babu ^a   Amooru, Damu G ^b   Subramanyam, Rajagopal ^a  

^a UNIVERSITY OF HYDERABAD   (India)

^b YOGI VEMANA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVONE; SERUM ALBUMIN; TRIMETHOXY FLAVONE; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; BINDING AFFINITY; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; CIRCULAR DICHROISM; CONFORMATION; CONTROLLED STUDY; FLUORESCENCE SPECTROSCOPY; HYDROGEN BOND; HYDROPHOBICITY; MASS SPECTROMETRY; MOLECULAR DOCKING; MOLECULAR INTERACTION; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; TEMPERATURE SENSITIVITY;

ALGORITHMS; CIRCULAR DICHROISM; FLAVONES; HUMANS; HYDROGEN BONDING; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

ANDROGRAPHIS; HEXAPODA;

EID: 77749317543     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008834     Document Type: Article

References (57)

1. Yang CS, Landau JM, Huang HMT (2001) Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21: 381-406.
2. Ren W, Qiao Z, Wang H, Zhu L, Zhang L (2003) Flavonoids: promising anticancer agents. Med Res Rev 23: 519-534.
3. Middleton E, Kandaswami C, Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751.
4. Amic D, Davidovic-Amic D, Beslo D, Trinajstic N (2003) Structure-radical scavenging activity relationships of flavonoids. Croatica chemica acta 76: 55-61.
5. Husain SR, Cillard J, Cillard P (1987) Hydroxyl radical scavenging activity of flavonoids. Phytochemistry 26: 2489-2491.
6. Jagetia GC, Venkatesha VA, Reddy TK (2003) Naringin, a citrus flavonone, protects against radiation-induced chromosome damage in mouse bone marrow. Mutagenesis 18: 337-343.
7. Afanaseva IB, Ostrakhovitch EA, Mikhalchik EV, Ibragimova GA, Korkina LG (2001) Enhancement of antioxidant and anti-inflammatory activities of bioflavonoid rutin by complexation with transition metals. Biochem pharmacol 61: 677-684.
8. Srivastava AK (1985) Inhibition of phosphorylase kinase, and tyrosine protein kinase activities by quercetin. Biochem Biophys Res Commun 131: 1-5.
9. Vlahos CJ, Matter WF, Hui KY, Brown RF (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248.
10. Boege F, Straub T, Kehr A, Boesenberg C, Christiansen K, et al. (1996) Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I. J Biol Chem 271: 2262-2270.
11. Dufour C, Dangles O (2005) Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy. BBA-General Subjects 1721: 164-173.
12. Obach RS (2000) Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther 294: 88-95.
13. Diniz A, Escuder-Gilabert L, Lopes NP, Rosa MaríaVillanueva- Camañas, Sagrado S, et al. (2008) Characterization of interactions between polyphenolic compounds and human serum proteins by capillary electrophoresis. Anal Bioanal Chem 391: 625-632.
14. Kirtikar KR, Basu BD (1975) Indian medicinal plants, Periodical Experts, New Delhi Vol 3: 1884-1886.
15. Chopra RN, Nayer SL, Chopra IC (1980) Glossary of Indian Medicinal Plants, CSIR. 18 p.
16. Rao YK, Damu AG, Rao AJ, Venkatesan S, Kuo PC, et al. (2003) Flavonoids from Andrographis viscosula. Chem Pharm Bull 51: 1374-1376.
17. Müller WE, Wollert U (1979) Human Serum Albumin as a 'Silent Receptor' for Drugs and Endogenous Substances. Pharmacology 19: 59-67.
18. Ahmad B, Parveen S, Khan RH (2006) Effect of albumin conformation on the binding of ciprofloxacin to human serum albumin: a novel approach directly assigning binding site. Biomacromolecules 7: 1350-1356.
19. Karnaukhova E (2007) Interactions of human serum albumin with retinoic acid, retinal and retinyl acetate. Biochem Pharmacol 73: 901-910.
20. Sinha SS, Mitra RK, Pal SK (2008) Temperature-dependent simultaneous ligand binding in human serum albumin. J Phys Chem B 112: 4884-4891.
21. Maiti TK, Ghosh KS, Samanta A, Dasgupta S (2008) The interaction of silibinin with human serum albumin: A spectroscopic investigation. J Photochem Photobiol A 194: 297-307.
22. He Y, Wang Y, Tang L, Liu H, Chen W, et al. (2008) Binding of puerarin to human serum albumin: a spectroscopic analysis and molecular docking. J Fluoresc 18: 433-442.
23. Charbonneau D, Beauregard M, Tajmir-Riahi HA (2009) Structural Analysis of Human Serum Albumin Complexes with Cationic Lipids. J Phys Chem B 113: 1777-1784.
24. Yue Y, Chen X, Qin J, Yao X (2009) Characterization of the mangiferin-human serum albumin complex by spectroscopic and molecular modeling approaches. J Pharm Biomed Anal 49: 753-759.
25. Varshney A, Sen P, Ahmad E, Rehan M, Subbarao N, et al. (2010) Ligand binding strategies of human serum albumin: How can the cargo be utilized? Chirality 22: 77-87.
26. Carter DC, Ho JX (1994) Structure of serum albumin. Adv Protein Chem 45: 153-203.
27. Peters T (1996) All about albumin: biochemistry, genetics, and medical applications. Academic Press. sandiego CA.
28. He XM, Carter DC (1992) Atomic structure and chemistry of human serum albumin. Nature 358: 209-215.
29. Curry S, Mandelkow H, Brick P, Franks N (1998) Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Mol Biol 5: 827-835.
30. Curry S, Brick P, Frank NP (1999) Atomic structure and chemistry of human serum albumin. Biochim Biophys Acta 1441: 131-140.
31. Sugio S, Kashima A, Mochizuki S, Noda M, et al. (1999) Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng Des Sel 12: 439-446.
32. Bhattacharya AA, Grüne T, Curry S (2000) Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J Mol Biol 303: 721-732.
33. Petitpas I, Grüne T, Bhattacharya AA, Curry S (2001) Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J Mol Biol 314: 955-960.
34. Ghuman J, Zunszain PA, Petitpas I, Bhattacharya AA, Otagiri M, et al. (2005) Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol 353: 38-52.
35. Petitpas I, Bhattacharya AA, Twine S, East M, Curry S (2001) Crystal structure analysis of warfarin binding to human serum albumin anatomy of drug site I. J Biol Chem 276: 22804-22809.
36. N'Soukpoe-Kossi CN, Sedaghat-Herati R, Ragi C, Hotchandani S, Tajmir-Riahi HA (2007) Retinol and retinoic acid bind human serum albumin: Stability and structural features. Int J Biol Macromol 40: 484-490.
37. Subramanyam R, Gollapudi A, Bonigala P, Chinnaboina M, Amooru DG (2009) Betulinic acid binding to human serum albumin: A study of protein conformation and binding affinity. J Photochem Photobiol B 94: 8-12.
38. Subramanyam R, Goud M, Sudhamalla B, Reddeem E, Gollapudi A, et al. (2009) Novel binding studies of human serum albumin with trans-feruloyl maslinic acid. J Photochem Photobiol B 95: 81-88.
39. Yi P, Qiu M (2008) 3D-QSAR and docking studies of aminopyridine carboxamide inhibitors of c-Jun N-terminal kinase-1. Eur J Med Chem 43: 604-613.
40. Jones G, Willett P, Glen RC (1995) Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J Mol Biol 245: 43-53.
41. Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267: 727-748.
42. Verdonk ML, Cole JC, Hartshorn MJ, Murray CW, Taylor RD (2003) Improved protein ligand docking using GOLD. Proteins: Struct. Funct. Genet 52: 609-623.
43. Shahper NK, Asad UK (2008) Computational simulation of mitoxantrone binding with human serum albumin. J Proteomics Bioinform S1: S017-S020.
44. Lehrer SS (1971) Solute perturbation of protein fluorescence. The quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion. Biochemistry 10: 3254-3263.
45. Sulkowska A (2002) Interaction of drugs with bovine and human serum albumin. J Mol Struct 614: 227-232.
46. Kandagal PB, Kalanur SS, Manjunatha DH, Seetharamappa J (2008) Mechanism of interaction between human serum albumin and N-alkyl phenothiazines studied using spectroscopic methods. J Pharm Biomed Anal 47: 260-267.
47. Froehlich E, Mandeville JS, Jennings CJ, Sedaghat-Herati R, Tajmir-Riahi HA (2009) Dendrimers bind human serum albumin. J Phys Chem B 113: 6986-6993.
48. Liang L, Tajmir-Riahi HA, Subirade M (2007) Interaction of ß-lactoglobulin with resveratrol and its biological implications. Biomacromolecules 9: 50-56.
49. Kragh-Hansen U (1990) Structure and ligand binding properties of human serum albumin. Dan Med Bull 37: 57-84.
50. Sengupta B, Sengupta PK (2002) The interaction of quercetin with human serum albumin: a fluorescence spectroscopic study. Biochem Biophys Res Commun 299: 400-403.
51. Jiang YL (2008) Design, synthesis and spectroscopic studies of resveratrol aliphatic acid ligands of human serum albumin. Bioorgan Med Chem 16: 6406-6414.
52. Bian Q, Liu J, Tian J, Hu Z (2004) Binding of genistein to human serum albumin demonstrated using tryptophan fluorescence quenching. Int J Biol Macromol 34: 275-279.
53. Zsila F, Bikbdi Z, Simonyi M (2003) Probing the binding of the flavonoid, quercetin to human serum albumin by circular dichroism, electronic absorption spectroscopy and molecular modelling methods. Biochem Pharmacol 65: 447-456.
54. Beauchemin R, N'Soukpoe-Kossi CN, Thomas TJ, Thomas T, Carpentier R, et al. (2007) Polyamine analogues bind human serum albumin. Biomacromolecules 8: 3177-3183.
55. Kanakis CD, Tarantilis PA, Polissiou MG, Diamantoglou S, Tajmir-Riahi HA (2006) Antioxidant flavonoids bind human serum albumin. J Mol Struct 798: 69-74.
56. Kosa T, Maruyama T, Otagiri M (1998) Species differences of serum albumins: II. Chemical and thermal stability. Pharmaceut Res 15: 449-454.
57. BK S, Ghosh GKS, Dasgupta DS (2009) Molecular interactions of isoxazolcurcumin with human serum albumin: spectroscopic and molecular modeling studies. Biopolymers 91: 108-119.